Claris Ventures makes equity investments in early stage biopharma companies with a clear vision and solid scientific evidence.

We are fascinated by science and we are committed to help the best innovators in addressing strong unmet clinical needs, spanning from rare diseases to oncology, immunology and other life threatening disease areas. We provide capital, competence and hands-on support to jump start clinical development programs and pursue value creation based on clinical evidence.


Supporting the best scientists in creating life science companies impacting people’s live

Claris Biotech I, the first fund to be raised by Claris Ventures, will be launched by end of 2019 and it will be focused on early stage biotech startups (investment range: from €500k to €5M).

- Hands-on collaboration with pre-clinical R&D centers to strengthen assessment capabilities
- Partnership with industry players to de-risk clinical development
- Top tier advisors and venture partners to maximize value creation

Phone: +39 011 3325889